Ticker Appearances
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis October 2023
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis August 2023
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Technical Strategy
LIVE Technical Stock Analysis May 2023
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Technical Strategy
Drilling down further into Energy- Laggards playing Catch-up
The rally continues and given Tuesday’s ability to close near highs of the session, while DeMark indicators remain early (by 3-4 days) it looks likely...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
First Word
COVID-19 UPDATE: Israel daily cases (per 1mm) now 26 vs 952 (Jan). ND and SD could see "obliteration" by June. Oil prices key to direction of Epicenter trade...
The lag between penetration of vaccines and cases falling is due to a few factors including the fact that vaccines take time to become effective. ...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis October 2023
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Live Technical Stock Analysis
LIVE Technical Stock Analysis August 2023
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Technical Strategy
LIVE Technical Stock Analysis May 2023
Mark will be conducting a live Webinar session for the most popular stocks requested by our subscribers. Mark will give his quick take (45 sec-1-minute...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Technical Strategy
Drilling down further into Energy- Laggards playing Catch-up
The rally continues and given Tuesday’s ability to close near highs of the session, while DeMark indicators remain early (by 3-4 days) it looks likely...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
First Word
COVID-19 UPDATE: Israel daily cases (per 1mm) now 26 vs 952 (Jan). ND and SD could see "obliteration" by June. Oil prices key to direction of Epicenter trade...
The lag between penetration of vaccines and cases falling is due to a few factors including the fact that vaccines take time to become effective. ...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
Unlock full access to Fundstrat’s research — now at our lowest price of 2025.
You’ve reached your 16 free reports this month.
Visitor: 0a50f6-761889-ba31af-78609b-7fcd0a Array ( [cookie] => 0a50f6-761889-ba31af-78609b-7fcd0a [current_usage] => 16 [max_usage] => 2 [current_usage_crypto] => 3 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.155 )
Articles Read 2/2
🎁 Unlock 1 extra article by joining our Community!
You’ve reached your limit of 2 free monthly articles. Please enter your email to unlock 1 more articles.
Already have an account? Sign In 0a50f6-761889-ba31af-78609b-7fcd0a
Already have an account? Sign In 0a50f6-761889-ba31af-78609b-7fcd0a
